Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Longevity Foundation
- Development stage
- Unknown
- Lead developer
- Jung+ Longevity
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Jung+ Longevity's Longevity Foundation is a nutraceutical supplement system designed to promote healthy aging and longevity by boosting cellular levels of nicotinamide adenine dinucleotide (NAD+). The formulation utilizes NAD+ precursors, such as niacin (nicotinamide), to provide the necessary substrate for NAD+-dependent enzymes, including sirtuins and poly ADP-ribose polymerases (PARPs). These enzymes play critical roles in regulating cellular metabolism, DNA repair, and mitochondrial function. Marketed as a two-part AM/PM system, the product aims to address the '12 hallmarks of aging' by aligning with the body's natural circadian rhythms. While not an FDA-approved pharmaceutical, it is positioned within the longevity medicine space as a small molecule intervention for cellular health.
- Brand names
- Longevity FoundationAdvanced Sleep RepairIntensive Recovery Protocol
- Other names
- NAD+nicotinamide adenine dinucleotideNAD+ precursorniacinnicotinamide
02
Targets
PARP (PARP family)SIRT (Sirtuin family)
Beyond the preview
Go deeper on Longevity Foundation.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Longevity Foundation.